Usefulness of Serial Monitoring of B-Type Natriuretic Peptide for the Detection of Acute Rejection After Heart Transplantation

American Journal of Cardiology

Volumn 103, Issue 8, 2009, Pages 1149-1153

  Garrido, Iris P ^a   Pascual Figal, Domingo A ^a   Nicolás, Francisco ^a   González Carrillo, Maria J ^a   Manzano Fernández, Sergio ^a   Sánchez Mas, Jesús ^a   Valdés Chavarri, Mariano ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYCLOSPORIN; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE RAFT REJECTION; ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; LUNG ARTERY PRESSURE; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BIOPSY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS;

EID: 63749099813     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.008     Document Type: Article

References (21)

1. Ationu A., Burch M., Singer D., Littleton P., and Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 27 (1993) 188-191
2. El Gamel A., Yonan N.A., Keevil B., Warbuton R., Kakadellis J., Woodcock A., Campbell C.S., Rahman A.N., and Deiraniya A.K. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg 63 (1997) 1095-1100
3. Arnau-Vives M.A., Almenar L., Hervas I., Osa A., Martinez-Dolz L., Rueda J., Zorio E., Martinez-Ortiz De Urbina L., Perez J.L., Mateo A., and Palencia M. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23 (2004) 850-856
4. Ogawa T., Veinot J.P., Davies R.A., Haddad H., Smith S.J., Masters R.G., Hendry P.J., Starling R., de Bold M.K., Ponce A., et al. Neuroendocrine profiling of humans receiving cardiac allografts. J Heart Lung Transplant 24 (2005) 1046-1054
5. Masters R.G., Davies R.A., Veinot J.P., Hendry P.J., Smith S.J., and de Bold A.J. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 100 (1999) 287-291
6. Wu A.H., Johnson M.L., Aaronson K.D., Gordon D., Dyke D.B., and Koelling T.M. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant 24 (2005) 52-57
7. Mehra M.R., Uber P.A., Potluri S., Ventura H.O., Scott R.L., and Park M.H. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 94 (2004) 454-458
8. Park M.H., Scott R.L., Uber P.A., Harris B.C., Chambers R., and Mehra M.R. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 90 (2002) 1326-1329
9. O'Neill J.O., McRae A.T., Troughton R.W., Ng K., Taylor D.O., Yamani M.H., Young J.B., and Starling R.C. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant 24 (2005) 416-420
10. Wu A.H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 152 (2006) 828-834
11. Miller W.L., Hartman K.A., Burritt M.F., Grill D.E., Rodeheffer R.J., Burnett Jr. J.C., and Jaffe A.S. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 116 (2007) 249-257
12. Bettencourt P., Azevedo A., Pimenta J., Friões F., Ferreira S., and Ferreira A. N-Terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
13. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., Andersen C.B., Angelini A., Berry G.J., Burke M.M., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
14. Shaw S.M., and Williams S.G. Is brain natriuretic peptide clinically useful after cardiac transplantation?. J Heart Lung Transplant 25 (2006) 1396-1401
15. Kirchoff W.C., Gradaus R., Stypmann J., Deng M.C., Tian T.D., Scheld H.H., Breithardt G., and Brisse B. Vasoactive peptides during long term follow up of patients after cardiac transplantation. J Heart Lung Transplant 23 (2004) 284-288
16. Lan Y.T., Chang R.K., Alejos J.C., Burch C., and Wetzel G.T. B-Type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 23 (2004) 558-563
17. Wang T.J., Larson M.G., Levy D., Leip E.P., Benjamin E.J., Wilson P.W., Sutherland P., Omland T., and Vasan R.S. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90 (2002) 254-258
18. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., Jacobsen S.J., Heublein D.M., and Burnett Jr. J.C. Aminoterminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 345-353
19. Tsutamoto T., Wada A., Sakai H., Ishikawa C., Tanaka T., Hayashi M., Fujii M., Yamamoto T., Dohke T., Ohnishi M., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47 (2006) 582-586
20. Pascual-Figal D.A., Domingo M., Casas T., Gish I., Ordoñez-Llanos J., Martinez P., Cinca J., Valdes M., Januzzi J.L., and Bayes-Genis A. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J 29 (2008) 1011-1018
21. Park M.H., Scott R.L., Uber P.A., and Mehra M.R. Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant 21 (2002) 613-614